SK28598A3 - Optically active phenyl pyrimidine derivative as analgesic agent - Google Patents
Optically active phenyl pyrimidine derivative as analgesic agent Download PDFInfo
- Publication number
- SK28598A3 SK28598A3 SK285-98A SK28598A SK28598A3 SK 28598 A3 SK28598 A3 SK 28598A3 SK 28598 A SK28598 A SK 28598A SK 28598 A3 SK28598 A3 SK 28598A3
- Authority
- SK
- Slovakia
- Prior art keywords
- salt
- enantiomer
- dichlorophenyl
- diamino
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9518027.9A GB9518027D0 (en) | 1995-09-05 | 1995-09-05 | Pharmacologically active compound |
| PCT/EP1996/003856 WO1997009317A2 (en) | 1995-09-05 | 1996-09-03 | Optically active phenyl pyrimidine derivative as analgesic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK28598A3 true SK28598A3 (en) | 1998-09-09 |
Family
ID=10780172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK285-98A SK28598A3 (en) | 1995-09-05 | 1996-09-03 | Optically active phenyl pyrimidine derivative as analgesic agent |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6124308A (hr) |
| EP (1) | EP0879230B1 (hr) |
| JP (1) | JPH11512108A (hr) |
| KR (1) | KR19990044397A (hr) |
| CN (1) | CN1200729A (hr) |
| AP (1) | AP640A (hr) |
| AR (1) | AR004192A1 (hr) |
| AT (1) | ATE203523T1 (hr) |
| AU (1) | AU710091B2 (hr) |
| BG (1) | BG65102B1 (hr) |
| BR (1) | BR9610388A (hr) |
| CA (1) | CA2230362A1 (hr) |
| CO (1) | CO4750651A1 (hr) |
| CZ (1) | CZ65598A3 (hr) |
| DE (1) | DE69614150T2 (hr) |
| EA (1) | EA000695B1 (hr) |
| ES (1) | ES2160834T3 (hr) |
| GB (1) | GB9518027D0 (hr) |
| HR (1) | HRP960399A2 (hr) |
| HU (1) | HUP9901260A3 (hr) |
| ID (1) | ID17274A (hr) |
| IL (1) | IL123414A0 (hr) |
| IS (1) | IS4673A (hr) |
| NO (1) | NO980923L (hr) |
| NZ (1) | NZ318390A (hr) |
| PL (1) | PL325329A1 (hr) |
| SK (1) | SK28598A3 (hr) |
| TR (1) | TR199800386T1 (hr) |
| TW (1) | TW367326B (hr) |
| WO (1) | WO1997009317A2 (hr) |
| YU (1) | YU49796A (hr) |
| ZA (1) | ZA967466B (hr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR016212A1 (es) * | 1998-04-28 | 2001-06-20 | Astra Ab | Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas |
| WO1999064045A1 (en) * | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Novel therapeutic agents for membrane transporters |
| US6420354B1 (en) | 1998-06-08 | 2002-07-16 | Advanced Medicine, Inc. | Sodium channel drugs and uses |
| GB9907965D0 (en) * | 1999-04-09 | 1999-06-02 | Glaxo Group Ltd | Medical use |
| US6479498B1 (en) | 1999-06-04 | 2002-11-12 | Theravance, Inc. | Sodium channel drugs and uses |
| NZ523851A (en) * | 2000-07-21 | 2004-09-24 | Ortho Mcneil Pharm Inc | A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| WO2002068398A1 (en) * | 2001-02-27 | 2002-09-06 | Teva Pharmaceutical Industries Ltd. | New crystal forms of lamotrigine and processes for their preparations |
| IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
| WO2003090693A2 (en) * | 2002-04-23 | 2003-11-06 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition containing lamotrigine particles of defined morphology |
| WO2004066987A2 (en) * | 2003-01-30 | 2004-08-12 | Dynogen Pharmaceuticals, Inc. | Use of sodium channel modulators for treating gastrointestinal tract disorders |
| GB0603087D0 (en) * | 2006-02-15 | 2006-03-29 | Glaxo Group Ltd | Novel use |
| EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| GB201111712D0 (en) | 2011-07-08 | 2011-08-24 | Gosforth Ct Holdings Pty Ltd | Pharmaceutical compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK153787C (da) * | 1979-06-01 | 1989-01-16 | Wellcome Found | Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved |
| FI895821A0 (fi) * | 1988-12-07 | 1989-12-05 | Wellcome Found | Farmaceutiskt aktiva cns foereningar. |
-
1995
- 1995-09-05 GB GBGB9518027.9A patent/GB9518027D0/en active Pending
-
1996
- 1996-09-03 SK SK285-98A patent/SK28598A3/sk unknown
- 1996-09-03 IL IL12341496A patent/IL123414A0/xx unknown
- 1996-09-03 CO CO96046885A patent/CO4750651A1/es unknown
- 1996-09-03 ID IDP962513A patent/ID17274A/id unknown
- 1996-09-03 KR KR1019980701641A patent/KR19990044397A/ko not_active Application Discontinuation
- 1996-09-03 JP JP9510854A patent/JPH11512108A/ja not_active Ceased
- 1996-09-03 BR BR9610388A patent/BR9610388A/pt not_active Application Discontinuation
- 1996-09-03 NZ NZ318390A patent/NZ318390A/xx unknown
- 1996-09-03 AT AT96931006T patent/ATE203523T1/de not_active IP Right Cessation
- 1996-09-03 PL PL96325329A patent/PL325329A1/xx unknown
- 1996-09-03 AU AU69865/96A patent/AU710091B2/en not_active Ceased
- 1996-09-03 WO PCT/EP1996/003856 patent/WO1997009317A2/en not_active Application Discontinuation
- 1996-09-03 CA CA002230362A patent/CA2230362A1/en not_active Abandoned
- 1996-09-03 HR HR9518027.9A patent/HRP960399A2/hr not_active Application Discontinuation
- 1996-09-03 DE DE69614150T patent/DE69614150T2/de not_active Expired - Lifetime
- 1996-09-03 ES ES96931006T patent/ES2160834T3/es not_active Expired - Lifetime
- 1996-09-03 HU HU9901260A patent/HUP9901260A3/hu unknown
- 1996-09-03 EP EP96931006A patent/EP0879230B1/en not_active Expired - Lifetime
- 1996-09-03 CZ CZ98655A patent/CZ65598A3/cs unknown
- 1996-09-03 EA EA199800189A patent/EA000695B1/ru not_active IP Right Cessation
- 1996-09-03 TR TR1998/00386T patent/TR199800386T1/xx unknown
- 1996-09-03 CN CN96197823A patent/CN1200729A/zh active Pending
- 1996-09-03 US US09/029,162 patent/US6124308A/en not_active Expired - Fee Related
- 1996-09-04 AR ARP960104220A patent/AR004192A1/es unknown
- 1996-09-04 ZA ZA9607466A patent/ZA967466B/xx unknown
- 1996-09-04 YU YU49796A patent/YU49796A/sh unknown
- 1996-09-05 TW TW085110879A patent/TW367326B/zh active
- 1996-09-06 AP APAP/P/1996/000857A patent/AP640A/en active
-
1998
- 1998-02-23 IS IS4673A patent/IS4673A/is unknown
- 1998-03-04 NO NO980923A patent/NO980923L/no not_active Application Discontinuation
- 1998-03-23 BG BG102342A patent/BG65102B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7531685B2 (en) | Deuterium-enriched oxybutynin | |
| US7750025B2 (en) | Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics | |
| SK390692A3 (en) | Quinuclidine derivatives, preparation method thereof and use | |
| US20040248956A1 (en) | Substituted imidazoles as cannabinoid receptor modulators | |
| US7888345B2 (en) | Benzaepinones as sodium channel blockers | |
| EP1870405A1 (en) | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands | |
| SK5592003A3 (en) | Lactam compound to inhibit beta-amyloid peptide release or synthesis | |
| KR20080063760A (ko) | 코르티코트로핀-방출 인자 (ｃｒｆ) 수용체 길항제로서유용한 피라졸로[1,5-알파]피리미디닐 유도체 | |
| HU221726B1 (hu) | Piperazinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására | |
| SK28598A3 (en) | Optically active phenyl pyrimidine derivative as analgesic agent | |
| EP0512901A1 (fr) | Composés polycycliques aminés et leurs énantiomères, procédé pour leur préparation et compositions pharmaceutiques en contenant | |
| JPH1171380A (ja) | ５Ｈ−チアゾロ（３，２−ａ）ピリミジン誘導体 | |
| DE60128587T2 (de) | Lactamverbindungen | |
| US20070185168A1 (en) | Piperidine derivatives | |
| EP4310080A1 (en) | Polymorphic forms of compound and preparation method therefor and application thereof | |
| JP2002538154A (ja) | セロトニン作動活性を有するｎ−置換イミド誘導体 | |
| JP2002527423A (ja) | ヒトｎｋ３受容体の選択的アンタゴニストとしてのウレイドピペリジン誘導体 | |
| MXPA98001680A (en) | Derivative of phenyl pyrimidine optically active as analges agent | |
| KR880001454B1 (ko) | 피리미도[4,5-g]퀴놀린 유도체 | |
| HU205751B (en) | Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same | |
| JP2005523936A (ja) | タムスロシン誘導体 | |
| JPH09505304A (ja) | 非ペプチド性タキキニン受容体拮抗物質 | |
| EP2093218A1 (en) | Arylalkyl substituted imidazolidinones |